Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joke Bilcke

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Pharmacoeconomics|June 3, 2009
Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sourcesJoke Bilcke, Philippe Beutels
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 15, 2021
Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better PracticeJoke Bilcke, Philippe Beutels
Pharmacoeconomics|September 27, 2022
Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine"Joke Bilcke, Philippe Beutels
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 26, 2018
Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster VaccinationJoke Bilcke, Frederik Verelst, Philippe Beutels
Plos One|July 18, 2014
Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at allJoke Bilcke, Samuel Coenen, Philippe Beutels
Lancet Regional Health. Americas|January 11, 2024
Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infantsXiao Li, Joke Bilcke, Philippe Beutels
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 29, 2017
Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regressionJoke Bilcke, Niel Hens, Philippe Beutels
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2008
Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in BelgiumJoke Bilcke, Pierre Van Damme, Philippe Beutels
Pharmacoeconomics|January 30, 2022
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated VaccineZoë Pieters, Benson Ogunjimi, Philippe Beutels, et al.
Human Vaccines & Immunotherapeutics|January 17, 2013
Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?Joke Bilcke, Albert Jan van Hoek, Philippe Beutels
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics|June 3, 2009
Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sourcesJoke Bilcke, Philippe Beutels
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 15, 2021
Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better PracticeJoke Bilcke, Philippe Beutels
Pharmacoeconomics|September 27, 2022
Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine"Joke Bilcke, Philippe Beutels
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 26, 2018
Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster VaccinationJoke Bilcke, Frederik Verelst, Philippe Beutels
Plos One|July 18, 2014
Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at allJoke Bilcke, Samuel Coenen, Philippe Beutels
Lancet Regional Health. Americas|January 11, 2024
Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infantsXiao Li, Joke Bilcke, Philippe Beutels
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|March 29, 2017
Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regressionJoke Bilcke, Niel Hens, Philippe Beutels
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2008
Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in BelgiumJoke Bilcke, Pierre Van Damme, Philippe Beutels
Pharmacoeconomics|January 30, 2022
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated VaccineZoë Pieters, Benson Ogunjimi, Philippe Beutels, et al.
Human Vaccines & Immunotherapeutics|January 17, 2013
Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?Joke Bilcke, Albert Jan van Hoek, Philippe Beutels
Pageof 6